Article may be outdated

This article is 14 days old. Some details may have changed since publication.

The Star·2 min read·medium

High prices prevent some parents from opting for vaccine

T
The Star
High prices prevent some parents from opting for vaccine
AI Summary

Parents in Malaysia are expressing concern over the high cost of the dengue vaccine, which is currently not subsidized by the government. While some parents view the cost as a barrier, others consider it a necessary expense to protect their children from the endemic virus.

Why it matters

The debate highlights the tension between public health accessibility and the financial burden of preventative medicine in developing economies.

Dive DeeperCreate a free account to unlock

PETALING JAYA: The dengue vaccine has been in the market for two years now, but many are still taking a wait-and-see approach due to the cost.

Others, however, are willing to fork out money for the jab for the sake of protection.

Teacher A. Nirmala said that while she is interested in getting her four children vaccinated against dengue, the cost is far from affordable.

“I surveyed a few places but they were charging over RM400 for two doses. It is not feasible,” she said.

“I hope the vaccine will be offered at government facilities, even if it is for a small fee.”

Nirmala added that since dengue is endemic in Malaysia, it would be helpful if the government could offer the vaccine at its facilities.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healtheconomy

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in